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Glial cell line-derived neurotrophic factor (GDNF) is proposed as a therapeutic tool
in Parkinson’s disease, addiction-related disorders, and neurodegenerative conditions
affecting motor neurons (MNs). Despite the high amount of work about GDNF
therapeutic application, the neuronal circuits requiring GDNF trophic support in the
brain and spinal cord (SC) are poorly characterized. Here, we defined GDNF and GDNF
family receptor-α 1 (GFRα1) expression pattern in the brain and SC of newborn and
adult mice. We performed systematic and simultaneous detection of EGFP and LacZ
expressing alleles in reporter mice and asked whether modifications of this signaling
pathway lead to a significant central nervous system (CNS) alteration. GFRα1 was
predominantly expressed by neurons but also by an unexpected population of non-
neuronal cells. GFRα1 expression pattern was wider in neonatal than in adult CNS and
GDNF expression was restricted in comparison with GFRα1 at both developmental time
points. The use of confocal microscopy to imaging X-gal deposits and EGFP allowed
us to identify regions containing cells that expressed both proteins and to discriminate
between auto and non-autotrophic signaling. We also suggested long-range GDNF-
GFRα1 circuits taking advantage of the ability of the EGFP genetically encoded reporter
to label long distance projecting axons. The complete elimination of either the ligand
or the receptor during development did not produce major abnormalities, suggesting a
preponderant role for GDNF signaling during adulthood. In the SC, our results pointed to
local modulatory interneurons as the main target of GDNF produced by Clarke’s column
(CC) cells. Our work increases the understanding on how GDNF signals in the CNS and
establish a crucial framework for posterior studies addressing either the biological role of
GDNF or the optimization of trophic factor-based therapies.
Keywords: trophic factors, GDNF, GFRα1, brain connectivity, Parkinson’s disease, addiction-related disorders,
motor neurons
INTRODUCTION
The glial cell line-derived neurotrophic factor (GDNF) belongs to a group of extracellular
ligands distantly related to the transforming growth factor superfamily (Airaksinen and Saarma,
2002). GDNF signals preferentially through extracellular GPI-anchored receptors, GDNF
family receptors-α (GFRα1–4), having stronger binding activity over GFRα1 (Trupp et al., 1998).
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GDNF–GFRα1 complexes recruit either the tyrosine kinase
transmembrane protein (RET) or the neural cell adhesion
molecule NCAM to initiate intracellular signaling (Durbec et al.,
1996; Jing et al., 1996; Trupp et al., 1996; Paratcha et al.,
2003). Additionally to the GFRα1 mediated responses, GDNF
can directly interact with either integrins or syndecan (Pascual
et al., 2011), although this signaling pathway has a smaller
contribution. From a functional point of view, GDNF was
originally identified as a potent trophic agent that promotes
differentiation and survival of dopaminergic neurons (Lin et al.,
1993), the main neuronal population affected in Parkinson’s
disease (de Lau and Breteler, 2006). In animals, GDNF is required
for the maintenance of the nigrostriatal pathway (Pascual et al.,
2008) and has been extensively used to ameliorate Parkinson’s
disease models (for reviews see Pascual et al., 2011; d’Anglemont
de Tassigny et al., 2015; Ibáñez and Andressoo, 2016). In
addition to their role in the nigrostriatal pathway, GDNF and
GFRα1 are expressed in the dopaminergic mesolimbic circuit
(ventral tegmental area—nucleus accumbens; Trupp et al., 1997;
Pascual et al., 2008; Hidalgo-Figueroa et al., 2012) where GDNF
has a role in survival and circuit functioning (Airavaara et al.,
2004; He et al., 2005; Pascual et al., 2008, 2011). Therefore,
GDNF was recently proposed as a potential therapy to treat
psychostimulant addictions to ethanol and opioids (Carnicella
and Ron, 2009). GDNF also has a strong protective effect
in vitro and in vivo over motor neurons (MNs; Henderson et al.,
1994; Oppenheim et al., 1995; Bohn, 2004). Adult MNs express
GDNF receptors and can bind, internalize and transport the
protein in both retro- and anterograde directions (Leitner et al.,
1999; Russell et al., 2000). Consequently, GDNF was considered
as a potential therapy to treat neurodegenerative disorders
associated with the loss of MNs like amyotrophic lateral sclerosis
(Bohn, 2004).
Genetically modified mouse models, in which expression of
reporter genes are driven either by the endogenous promoter
or transcriptional regulatory regions of a particular gene, are
a powerful tool to study gene expression patterns (see for
instance Gong et al., 2003). Genetic models have several
advantages, the reporter signal is stable and heritable and
permits, in some cases, the mapping of centimeter-long axons
(Feng et al., 2000).
GDNF expression was analyzed in rats by in situ hybridization
producing contradictory results, probably due to the different
sequences used as riboprobes (Trupp et al., 1997; Golden
et al., 1999; Barroso-Chinea et al., 2005). In our previous
characterization of the brain regions expressing GDNF, we used
two genetic engineered mice models. First, Gdnf−(LacZ)/+ mice
(Sánchez et al., 1996) allowed for the study of ß-galactosidase
(ß-gal) activity as a surrogate marker of the transcriptional
activity of the GDNF promoter. The expression pattern observed
in Gdnf−(LacZ)/+ mice closely matched the obtained using
in situ hybridization (Trupp et al., 1997; Pascual et al.,
2008; Hidalgo-Figueroa et al., 2012). The same mouse model
was used to map GDNF expression in the spinal cord (SC;
Hantman and Jessell, 2010). Second, Gdnf-Egfp is a transgenic
mouse line generated by the Gene Expression Nervous System
Atlas (GENSAT) project at Rockefeller University containing
a bacterial artificial chromosome, in which an EGFP coding
sequence was inserted after the initial ATG codon of the GDNF
sequence. Although this animal model did not fully reproduce
the expression pattern observed using in situ hybridization or
X-gal precipitate detection, an overall agreement was observed
(Hidalgo-Figueroa et al., 2012). The expression of GFRα1
has been previously studied using both in situ hybridization
and immunohistochemistry, but an extensive characterization
of the cell types expressing GFRα1 is lacking. Recently, a
genetic-modified Gfrα1 allele was described and is available
for detailed study. The Gfrα1−(Egfp)/+ reporter mouse carries a
Gfrα1 null and Egfp-targeted knock-in (KI) allele (Uesaka et al.,
2007).
Here we asked whether a combination of reporter mice
could enable the simultaneous identification of GDNF and
GFRα1 expressing cells. This study has not been previously
addressed mainly due to the lack of good antibodies and the
low expression levels of both proteins. Until recently, the use
of LacZ reporter mice for confocal studies was limited by
the ability of the anti-ß-gal antibody to detect the reporter
protein levels attained by a particular promoter. However, we
employed here a recently developed technique that exploits
the fluorescence of X-gal deposits (Hidalgo-Figueroa et al.,
2012; Levitsky et al., 2013) to perform confocal imaging of
EGFP (GFRα1 reporter) and X-gal (GDNF reporter) signals.
We also wondered if genetic deletion of GDNF or GFRα1
affects the survival or the maintenance of the identified neuronal
populations.
MATERIALS AND METHODS
Animals
Mice were housed under temperature-controlled conditions
(22◦C) in a 12 h light/dark cycle with access ad libitum to food
and water. Housing and treatments were performed according
to the animal care guidelines of European Community Council
(86/609/EEC). The Animal Research Committee at the Hospital
Universitario Virgen del Rocio approved all procedures. In every
experiment, both sexes were analyzed and no differences were
found between them. A description of the mouse lines used in
this study is presented in Supplementary Table 1, as well as their
corresponding figure.
Gfrα1Flox and Gfrα1−(Egfp)
Gfrα1Flox mice (a kind gift from J. Milbrandt, Washington
University School of Medicine, St. Louis, MO, USA) were
generated to conditionally inactivate GDNF receptor and to
investigate the physiological function of GDNF signaling in later
enteric nervous system development (Uesaka et al., 2007). This
mice have been used in the literature to analyze GDNF-GFRα1
signaling and site-specific gene expression (Uesaka et al., 2015;
Mwangi et al., 2016). In this line, CRE-mediated recombination
transforms the functional floxed GFRα1 allele, Gfrα1Flox, into a
null EGFP reporter allele, Gfrα1−(Egfp) (Figure 1A, left). Here
we generated the Gfrα1−(Egfp) allele by crossing Gfrα1Flox/+ mice
with Th-IRES-Cremice (Supplementary Table 1; Lindeberg et al.,
2004). The Th-IRES-Cre line showed Cre recombinase activity in
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the germline (Díaz-Castro et al., 2012), generating an ubicuous
Gfrα1−(Egfp) non-functional allele that expressed Egfp. Full
deletion of the receptor was generated by crossing Gfrα1−(Egfp)/+
mice and selecting both GFRα1 KO (Gfrα1−(Egfp)/−(Egfp)) and
control mice (Gfrα1−(Egfp)/+; Supplementary Table 1).
Gdnf−(LacZ)/+
To analyze GDNF expression, we used Gdnf−(LacZ)/+ mice
where LacZ gene is fused in frame to Gdnf exon I generating
a null reporter allele (Sánchez et al., 1996; Figure 1A,
center). This mice have been extensively used and validated
in function and expression analysis (Villadiego et al., 2005;
Pascual et al., 2008; Hidalgo-Figueroa et al., 2012; Muñoz-
Bravo et al., 2013). To simultaneously analyze Gdnf and
Gfrα1 expression patterns, we crossed Gdnf−(LacZ)/+ with
Gfrα1−(Egfp)/+ mice to generate the double heterozygous
(Gdnf−(LacZ)/+; Gfrα1−(Egfp)/+; Supplementary Table 1). Full
deletion of Gdnf was obtained in mice that also carry a copy of
the Gfrα1−(Egfp) allele by crossing Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+
with Gdnf−(LacZ)/+; Gfrα1+/+ mice. From this cross, we selected
GDNF KO (Gfrα1−(Egfp)/+; Gdnf−(LacZ)/−(LacZ)) as well as
control (Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+) mice (Supplementary
Table 1).
Gdnf-Egfp
To analyze projections from neurons expressingGdnf, transgenic
Gdnf-Egfp mice were obtained from GENSAT (RRID: nif-
0000-00130) on a mixed background (Gong et al., 2003).
This line was generated by random insertion of a bacterial
artificial chromosome containing regulatory sequences of Gdnf
expression followed by Egfp reporter gene (Figure 1A, right;
Supplementary Table 1). Gdnf-Egfp mice have been previously
validated for the analysis of Gdnf expression (Hidalgo-Figueroa
et al., 2012).
Emx1-Cre
We used Emx1-Cre mice (Gorski et al., 2002; RRID:
IMSR_JAX:005628) to check whether dorsal corticospinal
pathway cells, Emx1+, express GFRα1. First, we validated
recombination in these cells by crossing with recombination-
marker R26R-YFP line (RRID: IMSR_006148; Supplementary
Table 1). Secondly, we crossed Emx1-Cre line with Gfrα1Flox/+
mice, to generate Emx1Cre/+; Gfrα1Flox/+ mice (Supplementary
Table 1).
Histological Analyses
Tissue Preparation
To analyze brain expression, adult mice (postnatal day 30–90,
P30–P90) were anesthetized with intraperitoneal injection of
tiobarbital (Braun), and transcardially perfused with phosphate-
buffered saline (PBS) followed by 4% Paraformaldehyde (PFA,
Sigma) in PBS. Brains were removed immediately, post-fixed
overnight at 4◦C with the same fixative, included in gelatin
(Panreac) and cut in 50 µm thick coronal sections using a
vibratome (Leica). Preparation of neonatal brains (postnatal day
0–1, P0–P1) was similar, avoiding the initial perfusion step.
SC was removed from anesthetized mice and fixed overnight
(15 h) at 4◦C with 4% PFA in PBS. Tissue was incubated in
Sucrose 30% PBS overnight, included in OCT (Sakura) medium
and cut in 20 µm thick coronal cryostat sections (Leica).
Immunohistochemistry
For simultaneous histological detection of GDNF and GFRα1
expression in Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mice, the 5-bromo-
4-chloro-3-indolyl-D-galactopyranoside (X-gal) staining was
performed on every sixth section (adult mice) or every fourth
(neonatal mice). Sections were washed three times in Solution
C (MgCl2 2 mM, Sigma; Igepal 0.02%, Fluka; Na deoxycholate
0.01%, Sigma; EGTA 5 mM, Sigma; in PBS, pH 7.4) and
incubated overnight in staining solution (K3FeCN6 10 mM,
Sigma; K4FeCN6 10 mM, Sigma; 0.5 mg/ml X-gal, Sigma;
resuspended in N-N dimethylformamide, Sigma; in solution C).
This reaction was followed by an immunohistochemistry against
green fluorescent protein (antibody anti-GFP, 1:1000; Molecular
Probes Invitrogen; Cat# A11122; RRID: AB_2307355). For
immunohistochemistry reaction, tissue was permeabilized with
0.3% Triton X-100 (Sigma) in PBS for 10 min, washed twice
with 0.1% Triton X-100 in PBS, blocked in Gelatin 0.02%
solution in 0.25% Triton X-100 in PBS for 1 h and incubated
overnight at 4◦C with primary antibodies in blocking solution
(information about antibody characterization and working
dilution in Supplementary Table 2). After three washes with
0.1% Triton X-100 in PBS, slices were incubated with secondary
antibody anti-rabbit IgG conjugated with Alexa-488 (1:800; Life
Technologies, Cat# A11034; RRID: AB_10562715) and/or anti-
mouse IgG conjugated with Alexa-568 (1:800, Life Technologies;
Cat# A11031; RRID: AB_10562420). After two washes with PBS,
nuclei were stained with DAPI (Sigma, 1:1000). The sections
were mounted onto SuperFrost slides (Fisher Scientific), dried
and cover slipped with Dako fluorescent mounting medium
(Dako).
Antibody Specificity
Anti-GFP (1:1000; Molecular Probes Invitrogen; Cat# A11122
RRID: AB_2307355) is a rabbit polyclonal antibody (IgG
fraction) obtained after the immunization with GFP isolated
from Aequorae victoria. The antibody did not stain sections
from littermates that had not undergone Cre recombination,
therefore lacking EGFP expression. Moreover, the expression
pattern of GFRα1 analyzed by immunohistochemistry in
Gfrα1−(Egfp)/+, as well asGfrα1−(Egfp)/+;Gdnf−(LacZ)/+ mice was
similar to previous studies (Trupp et al., 1997; Golden et al.,
1999).
Anti-BrdU (1:200; rat, Abcam, Cat# AB6326; RRID: AB_305426)
is a rat monoclonal antibody that detects nucleated cells in
S-Phase that have incorporated BrdU, as a thymidine analog,
into their DNA. The specificity of the antibody was tested
by immunohistochemistry on SC from mice descendent from
females not injected with BrdU during pregnancy.
Anti-NeuN (1:500, mouse, Merck Cat# MAB377 RRID:
AB_11210778) is a mouse monoclonal antibody against a
neuron-specific nuclear protein (Neuronal Nuclei, NeuN). It has
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been probed specific as a neuronal marker which labels neuronal
nuclei in a pattern similar to published (Mullen et al., 1992).
Imaging and Data Analysis
Low Magnification Analysis
First, we imaged whole brain sections with a fluorescence and
light microscope (objective 40×/0.95, Olympus BX-61) and
the Superimage composition tool included in the NewCAST
Software package (Visiopharm). Superimages obtained with this
system were edited in Adobe Photoshop CS5 Software in order
to adjust brightness, contrast and sharpness. Second, by visual
microscopy analysis (40×/0.95, Olympus BX-61 and NewCAST,
Visiopharm) we identified X-gal precipitates in bright field and
locate their position in the brain, in at least three mice by age
for every structure. Using Adobe Photoshop CS5, we manually
added a blue area to the Superimage in the same area where the
signal was detected by bright field microscopy. Then, anatomical
identification of brain structures was done by comparison with
Allen Reference Atlas (RRID: nlx_21010; Lein et al., 2007) for
adult mice and with the Atlas of the developing mouse brain for
neonatal animals (Paxinos et al., 2007). High-resolution figures
are available under request.
High Magnification Analysis
GDNF and GFRα1-positive areas were later imaged at high
magnification using a confocal microscope (Objective plan APO
60×/1.40 Oil, Nikon A1R+) in Z-Stacks compositions of 10–20
optical planes of 1 µm thickness. Using both visual microscopy
analysis and image analysis, we classified expression as neuronal
(identified by NeuN positive marker), cellular (NeuN negative)
or axonal (identified by morphology using high magnification
analysis). Every brain structure was classified by analysis of at
least three mice by age.
Colocalization Confocal Analysis
Confocal images to probe colocalization of X-gal precipitates and
GFP fluorescent signal were acquired using a Leica TCS SP2
microscope, as described (Levitsky et al., 2013). This technique,
based on X-gal fluorescence emission and mathematical optical
correction, allows to directly image X-gal staining on thick
tissue sections by confocal microscopy. As there is not need to
use specific antibodies against ß-gal, this technique has lower
detection threshold, high specificity and reliability. Its use has
been previously validated for the detection of GDNF-positive
cells (Hidalgo-Figueroa et al., 2012). Using this technique,
we systematically analyzed colocalization of X-gal perinuclear
precipitates with anti-EGFP inmunofluorescent signal in at least
three mice.
BrdU Tracing and Quantification
At chosen embryonic development days (from embryonic day
9–15, E9–E15), a single intraperitoneal injection of BrdU (Sigma,
15 mg/mL in PBS and 50 mg/kg of body weight) was performed
in pregnant Gdnf-Egfp mice derived from timed mating. Pumps
were sacrificed at P7, and immunostaining anti-GFP in every
fourth section of SC was performed as explained. Immediately
after, samples were post-fixated with 4% PFA for 1 h and
treated with 2 M HCl for 20 min to denature DNA, followed
by incubation with 0.1 M sodium borate, pH 8.5 for 10 min to
neutralize HCl. Sections were subjected to heat-induced antigen
retrieval in sodium citrate buffer 0.01 M, pH 6.0 at 95◦C. After
that, the standard protocol described above was performed, using
an anti-BrdU primary antibody (1:200, rat, Abcam Cat# AB6326,
RRID: AB_305426) and an anti-IgG rat conjugated to Alexa-546
as a secondary antibody (1:500, Life Technologies Cat# A11081
RRID: AB_10563603). Quantification of GDNF+ cells in SC was
done manually, by counting all the positive cells on every fourth
section (20 µm) from second vertebrae at thoracic (T2) to first
at sacral level (S1). The SC from three mice of every age were
quantified.
RESULTS
Experimental Models
To characterize the expression sites of both GFRα1 and
GDNF, we employed three well-characterized genetic models
(Figure 1A, Supplementary Table 1 and see ‘‘Materials and
Methods’’ Section). GFRα1 expression was followed using a
heterozygous allele where the wild-type sequence has been
substituted by an Egfp (Gfrα1−(Egfp)/+, Uesaka et al., 2007).
GDNF expression was analyzed using both a heterozygous KI
allele, where the Gdnf promoter drove the expression of a LacZ
gene (Gdnf−(LacZ)/+, Sánchez et al., 1996), and a heterozygous
random insertion of a bacterial artificial chromosome containing
the Gdnf genomic region, where the coding sequence has been
replaced by an Egfp (Gdnf-Egfp, Gong et al., 2003).
Adult Brain Regions Expressing GDNF
and GFRα1
In order to gain an understanding of the adult expression pattern
of GFRα1 and GDNF, we described the expression of EGFP
and ß-gal in Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mice. Areas with
expression of both proteins were characterized, were depicted
in Figure 1B and listed in Supplementary Table 3 according
to Allen Brain Atlas categorization. Cells were classified as
neurons when immunohistochemistry against NeuN showed
colocalization with the anti-EGFP signal in Gfrα1−(Egfp)/+;
Gdnf−(LacZ)/+ brain sections (data not shown). The number
of cells with GDNF or GFRα1 expression in a particular
structure was represented with a semi-quantitative scale in
Supplementary Table 3. Regions with neuronal projections
were also shown in Supplementary Table 3 and, again, a
semi-quantitative scale was used to classify the intensity of
the expression. To put our finding in context, we also
described if the identified area with either GDNF or GFRα1
expression was already described in the literature or is a
new finding of this study (Supplementary Table 3). Areas
with GFRα1 expression were imaged at high-magnification
using confocal microscopy (Figures 2, 3) and details of
the GDNF expression in Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ and
Gdnf-Egfp brains can be observed at high resolution in
Figures 4, 5. The GDNF expressing areas observed in the
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FIGURE 1 | Adult expression of GDNF family receptor-α 1 (GFRα1) and Glial cell line-derived neurotrophic factor (GDNF). (A) Schematic drawing of the
mice models used in this work. Gfrα1Flox and Gfrα1−(Egfp). Gfrα1Flox allele: functional Gfrα1 cDNA (purple box) flanked by loxP sites (black triangles) disrupts Gfrα1
wild-type allele. Cre-recombinase activity (dotted line) generates Gfrα1−(Egfp) knock-out (KO) allele and enables Egfp expression (green box). Gdnf−(LacZ) allele: LacZ
gene (blue box) fused in frame to Gdnf exon I to generate a null allele. Gdnf-Egfp: random insertion of bacterial artificial chromosome (BAC RP23-32D22)
incorporating Egfp gene (green box) in frame with Gdnf initial ATG. (B) Expression of GFRα1 (anti-EGFP, green) and GDNF (X-gal positive, blue areas drawn over left
hemispheres) in 50 µm-thick coronal brain sections from 1-month-old Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse. Scale bar represents 5 mm. Distance from bregma (B) is
indicated (mm). Abbreviations are listed in Supplementary Table 3.
Gdnf−(LacZ)/+ mouse were confirmed in brain coronal sections
from Gdnf-Egfp animals (Supplementary Figure 1). To further
confirm the identity of the brain nuclei with GFRα1 and GDNF
expression, we also analyzed sagittal sections fromGfrα1−(Egfp)/+
and Gdnf-Egfp mice (data not shown and Supplementary
Table 3).
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FIGURE 2 | Detail of anterior GFRα1-positive areas in the adult Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse brain. (A–I) Coronal brain sections immunostained with
an anti-EGFP antibody (green). Yellow-labeled panels: low magnification images indicating the position of confocal images. White-labeled panels: confocal images,
Z-stacks projections of 10–20 optical planes (1 µm thickness). Scale bars represent 1 mm in yellow-labeled panels and 50 µm in white-labeled panels. Abbreviations
are listed in Supplementary Table 3, except for gl, glomerular layer. Images are oriented so that up is dorsal, and midline is in the left part of the panels. Distance from
bregma (B) is indicated (mm) in low magnification images.
Neonatal Brain Regions Expressing GDNF
and GFRα1
To compare adult and perinatal expression of GDNF
and GFRα1, we characterized the brain from perinatal
Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ animals. Representative
images of the regions with the expression of both
ligand and receptor along the brain were depicted in
Supplementary Figure 2 and the hierarchical classification
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FIGURE 3 | Detail of posterior GFRα1-positive areas in the Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse brain. (A–H) Coronal brain sections immunostained with an
anti-EGFP antibody (green). Yellow-labeled panels: low magnification images indicating the position of confocal images. White-labeled panels: confocal images,
Z-stacks projections of 10–20 optical planes (1 µm thickness). Scale bars represent 1 mm in yellow-labeled panels and 50 µm in white-labeled panels. Abbreviations
are listed in Supplementary Table 3, except for LGd and LGv, dorsal (d) and ventral (v) parts of the lateral geniculate complex; LA, lateral amygdalar nucleus; MEA,
medial amygdalar nucleus; and SUBd and SUBv, dorsal (d) and ventral (v) parts of subiculum (SUB). Red dotted line in (A,D,F) panels indicate midline. Images are
oriented so that up is dorsal, and midline is in the left part of the panels. Distance from bregma (B) is indicated (mm) in low magnification images.
of the structures was described in Supplementary
Table 4. Areas with perinatal but without adult GFRα1
expression were imaged using confocal microscopy
(Figure 6). To further verify the brain nucleus
expressing GDNF, we characterized coronal brain
sections from neonatal Gdnf-Egfp animals (Supplementary
Figure 3).
Our previous work has shown that GDNF expression is
very reduced in the brain during embryonic development
(Hidalgo-Figueroa et al., 2012). In order to test the relevance
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FIGURE 4 | Detail of anterior GDNF-positive areas in the adult Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ and Gdnf-Egfp mouse brains. (A–E) Modified schemes from
Allen Brain Atlas indicate localization of high-magnified pictures (red squares) and GDNF-positive areas (blue). Distance from bregma (B) is noted (mm). Bright field
images from Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ show X-gal deposits (blue arrowheads when required). Confocal images (Z-stacks projections of 10–20 optical planes of
1 µm thickness) from Gdnf-Egfp (anti-EGFP, green). Scale bars indicate 50 µm. Abbreviations are listed in Supplementary Table 3. Images are oriented so that up is
dorsal, and midline is in the left part of the panels.
of GFRα1 and GDNF function in the maintenance of the cells
described in Supplementary Figures 2, 6 and Supplementary
Table 4, we took advantage of the reporter activity of
the non-functional Gfrα1−(Egfp) allele, which allowed us
to label knocked-out cells. Figure 7 shows cells where
GFRα1 has been depleted (embryonic GFRα1 knock-out
(KO); Gfrα1−(Egfp)/−(Egfp)) compared with heterozygous
(Gfrα1−(Egfp)/+, control) littermates at birth. Similarly,
Figure 8 shows the GFRα1 expression pattern in animals
lacking GDNF expression (embryonic GDNF KO) that also
carry the Gfrα1−(Egfp) allele, to visualize GFRα1 positive cells
(Gfrα1−(Egfp)/+; Gdnf−(LacZ)/−(LacZ)). Double heterozygous
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FIGURE 5 | Detail of posterior GDNF-positive areas in the adult Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ and Gdnf-Egfp mouse brains. (A–D) Modified schemes from
Allen Brain Atlas indicate localization of high-magnified pictures (red squares) and GDNF-positive areas (blue). Distance from bregma (B) is noted (mm). Bright field
images from Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ show X-gal deposits (blue arrowheads when required). Confocal images (Z-stacks projections of 10–20 optical planes of
1 µm thickness) from Gdnf-Egfp (anti-EGFP, green). Scale bars indicate 50 µm. Abbreviations are listed in Supplementary Table 3. Images are oriented so that up is
dorsal, and midline is in the left part of the panels. Red dotted line in (C) indicates midline.
littermates were used as control animals (Gfrα1−(Egfp)/+;
Gdnf−(LacZ)/+). As expected, no major abnormalities
in the GFRα1 expression pattern were detected in the
absence of trophic support, strongly suggesting that GDNF-
GFRα1 signaling pathway is not strongly required during
development for the survival of these cells. However, we
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FIGURE 6 | Detail of areas GFRα1-positive and GDNF-positive in the perinatal but not adult mouse brains. (A–E) Detail of GFRα1-positive areas in coronal
brain sections from newborn Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mice immunostained with an anti-EGFP antibody (green). Yellow-labeled panels: low magnification images
indicating the position of confocal images. White-labeled panels: confocal images, Z-stacks projections of 10–20 optical planes (1 µm thickness). Scale bars
represent 500 µm in yellow-labeled panels and 50 µm in white-labeled panels. (F) Detail of GDNF-positive area in the brain of neonatal Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+
and Gdnf-Egfp mice. Left: modified atlas scheme (Paxinos et al., 2007) indicates localization of high-magnified pictures (in red). Center: bright field image from
Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ (X-gal positive, blue arrowheads). Right: confocal image (Z-stacks projection of 10–20 optical planes of 1 µm thickness) from
Gdnf-Egfp (immunostaining anti-EGFP, green). Scale bars represent 50 µm. In the entire figure, abbreviations are listed in Supplementary Table 4. In
low-magnification panels, distance from the most anterior part of the brain is indicated (mm). Images are oriented so that up is dorsal and midline is in the left part of
the panels. Red dotted line in (C) indicates midline.
cannot discard small differences in the number of cells
or projections and more quantitative approaches will be
required to establish the role of GDNF signaling during
development.
GDNF and GFRα1 Positive Axonal
Projections
Our previous study has identified neurons as the main brain cells
expressing GDNF (Hidalgo-Figueroa et al., 2012). Unexpectedly,
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FIGURE 7 | Absence of brain phenotype in mice lacking GFRα1 at birth. Coronal brain sections from Gfrα1−(Egfp)/+ (control) and Gfrα1−(Egfp)/−(Egfp) (Gfrα1−/−;
Gfrα1 knockout) newborn mice immunostained with an anti-EGFP antibody (green). Scale bar represents 1.2 mm. Abbreviations are listed in Supplementary Table 4
and distance from the most anterior part of the brain is noted (mm).
analysis of Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mice showed that
GFRα1 was not only expressed by neurons in the adult brain, but
also by non-neuronal cells (Figure 9A). One of the advantages
of the technology used here is that, thanks to the uniform
distribution of EGFP in neurons, we can describe the brain
areas innervated by projection neurons. Previous studies have
shown the positive response of substantia nigra compact cells to
striatal GDNF (for a review see d’Anglemont de Tassigny et al.,
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FIGURE 8 | Absence of brain phenotype in mice lacking GDNF at birth. Coronal brain sections from Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ (control) and Gfrα1−(Egfp)/+;
Gdnf−(LacZ)/−(LacZ) (Gdnf knockout) newborn mice immunostained with an anti-EGFP antibody (green). Scale bar represents 1.2 mm. Abbreviations are listed in
Supplementary Table 4 and distance from the most anterior part of the brain is noted (mm).
2015), that is produced by local interneurons (Hidalgo-Figueroa
et al., 2012) and exerts its action on GFRα1 positive substantia
nigra compact axonal terminals. This well-known long-distance
trophic interaction was confirmed here (Figures 1–3), validating
the approach. In addition, we also observed a GFRα1 positive
axonal tract corresponding with the mammilothalamic tract
that is initiated in the SUB and reach the mammillary nucleus
after passing through GDNF positive areas, including the
medial septum and the anterior thalamus (Figure 9B and
Supplementary Tables 3, 4). Similarly, GFRα1 positive axons
from the medial habenula (MH) reach the interpeduncular
nucleus (IPN), GDNF positive during postnatal development
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FIGURE 9 | Long and short-distance trophic GDNF-GFRα1 interactions (I): non-neuronal GFRα1 positive cells; subicular neurons. Coronal brain sections
from adult Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse immunostained with an anti-EGFP antibody (green). (A) Non-neuronal GFRα1 positive cells homogeneously
distributed over the whole brain. CP: Caudoputamen. Scale bars represent 600 µm. (B) GFRα1 expression in the mammillothalamic tract (mtt) originated in the SUB
and navigating until the mammillary body (MBO). Upper panels (yellow labeled) show low-magnification images. Bottom panels are confocal images (Z-stack
projection of 10–20 optical planes of 1 µm thickness) from SUB (red square in upper panel), MBO (yellow square in upper panel) and mtt (red square in upper panel).
Yellow square in MBO is shown at high magnification as an inset. Scale bars are 600 µm in upper panels, 200 µm in bottom left, right and center panel-inset, and
400 µm in the center panel. In the entire figure, distance from bregma (B) is indicated (mm).
(Figure 10), through the fasciculus retroflexus. In the cerebellum,
we found another example of local production of GDNF by
interneurons in regions containing GFRα1 positive terminals
(Figure 11A).
Finally, analysis of Gdnf-Egfp mouse brains revealed GDNF
positive axons that reach both the claustrum (CLA) and
amygdala (AMG; Figure 11B).
Regions with Simultaneous Local
Expression of GDNF and GFRα1
We identified several regions with local expression of both
GFRα1 and GDNF including brain areas that a previous
report has failed to detect (Supplementary Tables 3, 4).
Regions with intermingled somatic expression of both the
ligand and the receptor include substantia innominata
(SI), ACB, caudoputamen, septum, midbrain reticular
nucleus (MRN), and olfactory tubercle (OT) in adult
animals; and oculomotor nucleus (III), locus ceruleus
(LC) and the V motor nucleus of trigeminal in neonatal
mice. In order to systematically define the cells expressing
both markers, we made a detailed analysis of these areas
by confocal microscopy. In most of the adult animals,
no single colocalization GDNF-GFRα1 was observed in
neurons despite the high level of expression of both markers
(Figure 12). Apart from neurons, the secretory cells of
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FIGURE 10 | Long and short-distance trophic GDNF-GFRα1 interactions (II): fasciculus retroflexus. GFRα1 and GDNF expression in the fasciculus
retroflexus tract (fr, red arrows), initiated in medial habenula (MH) neurons projecting to the interpeduncular nucleus (IPN). Sagittal (A) and coronal (B) brain sections
from adult Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse immunostained with an anti-EGFP antibody (green). Scale bars are 600 µm. (C) Coronal brain section from newborn
Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse showing GFRα1 expression (anti-EGFP, green), GDNF expression (X-gal positive, red, white arrowheads) and DAPI staining
(blue). Left panel: red square indicates localization of confocal images. Middle panel: confocal Z-stack projection of 10–20 optical planes of 1 µm thickness. Right
panel: individual optical plane. Scale bars are 200 µm in left panel and 20 µm in central and right panels. A partial view of the mtt is also visible (yellow arrowheads
in B). Distance from midline (L) in (A), bregma (B) in (B) or the most anterior part of the brain (C) is noted (mm).
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FIGURE 11 | Long and short-distance trophic GDNF-GFRα1 interactions (III): cerebellum; GDNF positive axons. (A) GFRα1 and GDNF expression in the
granular layer of the cerebellar cortex (CBXgr). Sagittal brain sections from Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ (left, 1st and 2nd panels) and Gdnf-Egfp (right, 3rd and 4th
panels) immunostained with an anti-EGFP antibody (green). Yellow labeled panels: localization of high-magnification images (white square). White labeled panels:
high-magnification of CBXgr. Scale bars represent 600 µm in low-magnification images and 200 µm in high-magnification images. Distance from midline (L) is
indicated (mm). (B) Brain areas with local GFRα1 expression innervated by GDNF positive axons. Left panel: modified scheme from Allen Brain Atlas showing the
localization of claustrum (CLA, yellow) and different nuclei of the amygdala (AMG, red, blue and pink). Brain coronal sections from Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+
(middle panel) and Gdnf-Egfp (right panel) immunostained with an anti-EGFP antibody (green). Distance from bregma (B) is indicated (mm). CLA, yellow arrowheads;
and AMG, red and blue arrowheads are shown. Bottom panel: confocal Z-stack projection of 10–20 optical planes of 1 µm thickness from the area inside the yellow
square in upper-right panel. Scale bars represent 600 µm (upper panels) and 50 µm (bottom panel). Abbreviations are listed in Supplementary Table 3.
the subcomissural organ produced both markers (data not
shown). In newborn animals, GFRα1 and GDNF expressing
cells were intermingled but no single neuron was found
expressing both markers in the III, cuneiform nucleus
(CUN) or LC (Figure 13). On the contrary, in the adult
MRN and the neonatal V motor nucleus of trigeminal we
observed not only neurons expressing both markers but also
cells that independently produce either GFRα1 or GDNF
(Figure 14).
GFRα1 and GDNF Expression in The Spinal
Cord
Additionally to the well-documented expression of GFRα1 by
the MNs of the SC, GDNF is expressed by Clarke’s column
Frontiers in Neuroanatomy | www.frontiersin.org 15 June 2016 | Volume 10 | Article 73
Ortega-de San Luis and Pascual GDNF-GFRα1 CNS Expression Pattern
FIGURE 12 | Brain regions expressing GFRα1 and GDNF in different cell types in the adult brain. (A–C) Coronal brain sections from adult Gfrα1−(Egfp)/+;
Gdnf−(LacZ)/+ mouse showing GFRα1 (anti-EGFP, green) and GDNF (X-gal positive in red, white arrowheads) expression. Yellow labeled panels indicate localization of
areas of interest. White labeled panels are confocal images of the areas of interest from one optical plane. In confocal images, DAPI staining is shown (blue). Scale
bars are 600 µm in yellow-labeled panels and 20 µm in confocal images. See Supplementary Table 3 for abbreviations. Distance of the coronal section from bregma
(B) is indicated (mm).
(CC) neurons (Hantman and Jessell, 2010). We characterized
the expression pattern of GDNF in newborn Gdnf-Egfp mice.
According to the anatomical location of CC, GDNF positive
cells were found in vertebrae of the thoracic and lumbar levels
(Figure 15A). We observed a second type of GDNF positive
cells localized in the ventral horn (ventrolateral position) of
most caudal vertebrae (mainly lumbar; Figure 15D). These
cells could correspond with especial CC cells that have been
described in humans in this position (Gray, 1918). Regarding
the temporal distribution of the cells, GDNF expression was
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FIGURE 13 | Brain regions expressing GFRα1 and GDNF in different cell types in the neonatal brain. (A–C) Coronal brain sections from neonatal
Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse showing GFRα1 (anti-EGFP, green) and GDNF (X-gal positive, red, white arrowheads) expression. Yellow-labeled panels indicate
localization of areas of interest. White labeled panels are confocal images of areas of interest from one optical plane. In confocal images, DAPI staining is shown
(blue). Scale bars are 600 µm in yellow-labeled panels and 20 µm in confocal images. CUN, Cuneiform nucleus; III, Oculomotor nucleus; LC, Locus ceruleus.
Distance from the most anterior part of the brain (mm) is indicated.
barely detected in the CC at embryonic day 16 (E16), a
peak of maximal expression was observed at postnatal day
12 (P12) and GDNF expression was turned off at P25
(Figures 15A–C and data not shown). At P0, cells with a different
morphology were also observed around midline (Figure 15D),
which could be reminiscent of the cells described during
development to modulate midline crossing of commissural
axons (Charoy et al., 2012). In order to define when GDNF
positive cells were born, we used BrdU tracing. We injected
pregnant Gdnf-Egfp mice with BrdU at embryonic days from
E9 to E15 and the animals were sacrificed at P7 to analyze
GDNF expression. As observed in Figure 15E, the CC cells
that will express GDNF during the perinatal period were
born at E11.
In order to suggest a possible trophic circuit in the SC,
we studied the expression of GFRα1 in the perinatal SC.
CC cells send their axon to the cerebellum and receive
information from primary sensory neurons, cortical neurons
and local GABAergic interneurons (Hantman and Jessell,
2010). Analysis of perinatal Gfrα1−(Egfp)/+ mice indicated
that several interneurons localized in the dorsal horn and
around the CC are positive for GFRα1 (Figure 15F). As
previously described, MNs of the ventral horn also expressed
low levels of the receptor (Figure 15F). However, axons
coming from the cortex through the dorsal corticospinal
tract (dCST), positive for Emx1 marker, were negative
for GFRα1 expression, suggesting that interneurons more
than cortical neurons were the main target of the secreted
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FIGURE 14 | Brain regions expressing both GFRα1 and GDNF in the same neuron. Coronal brain sections from adult (A) or neonatal (B) Gfrα1−(Egfp)/+;
Gdnf−(LacZ)/+ mouse showing GFRα1 (anti-EGFP, green) and GDNF (X-gal positive in, red) expression. Left panels: modified scheme from Franklin and Paxinos
(1997) (A) or Paxinos et al. (2007) (B) showing the localization of areas of interest. Yellow labeled panels: low-magnification coronal brain sections of the same region.
White labeled panels are confocal images, one optical plane, of the areas of interest. Yellow arrowheads indicate X-gal deposits inside EGFP positive cell. White
arrowheads indicate X-gal deposits inside non-EGFP positive cells. In confocal images, DAPI staining is shown (blue). Scale bars are 600 µM in low magnification
and 20 µm in confocal images. MRN, Midbrain reticular nucleus; V, V motor nucleus of trigeminal. Distance of the coronal section is indicated from bregma (B) in
panel (A), or from the most anterior part of the brain in panel (B) (mm).
GDNF in the SC (Figures 15F,G). As a control, we
verified that genetic labeling with EGFP of cortical cells
(Emx1+) projecting to CC could be revealed by our analysis
(Figure 15G).
DISCUSSION
Trophic factors have been postulated as promising therapies
for central nervous system (CNS) diseases; however, initial
excitement was cooled down by clinical trials, which revealed
difficulties in the administration and severe negative effects
of the dispensed treatments (Nutt et al., 2003; Tovar-Y-
Romo et al., 2014). The translation to the clinics of these
therapies will be facilitated by improved knowledge about CNS
GDNF-GFRα1 trophic circuits and how brain connectivity
is regulated during development by this signaling pathway.
In this article, we performed the simultaneous detection of
GDNF and GFRα1 expression patterns, complementing previous
studies using in situ hybridization (Trupp et al., 1997; Golden
et al., 1999) or analysis of reporter mice (Pascual et al.,
2008; Hidalgo-Figueroa et al., 2012). Our work presents several
advantages and caveats. The technique employed here allowed
us to simultaneously observe both the soma and projections
of the neurons expressing the ligand or the receptor and
therefore, to describe the projection neurons that express
both molecules. Second, we benefited here from the high
sensitivity and stability of the signal from reporter mice. Last,
the use of reporter mice allowed us for an exhaustive and
detailed analysis that could be crucial for the understanding
of the physiology of GDNF and to improve GDNF-based
therapies.
A drawback of our method is that transgenic mice could
not recapitulate the expression of the endogenous loci, although
the use of KI animals decreases the possibility of observing
an abnormal pattern of expression. However, our results are
highly compatible with analysis published before (Trupp et al.,
1997; Golden et al., 1999) and show other expression sites
that have been previously missed, probably because their low
expression level, the lack of sensitivity of mRNA detection, and
the shorter life of mRNA in the cell compared with EGFP
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FIGURE 15 | Expression of GFRα1 and GDNF in the spinal cord (SC). (A,B) Number of cells expressing GDNF along the SC at several postnatal (P) days as
observed in Gdnf-Egfp mice immunostained with an against EGFP antibody (green). In blue, Clarke’s column (CC) cells; in red, ventrolateral-located GDNF positive
cells. (A) number of EGFP positive cells per vertebra. X-axis indicates the vertebrae position in the thoracic (T), lumbar (L) and sacral (S) level. (B) Total number of
GDNF positive cells. (C–E) SC sections from Gdnf-Egfp mouse at thoracic level. (C) Representative images of CC cells at several postnatal days (anti-EGFP, green,
and DAPI, blue). In P15, inset (white square) is shown at high magnification. Scale bars are 200 µm and 80 µm in inset. (D) Ventrolateral (white arrowhead) and
midline (white line) located populations of GDNF expressing cells (immunostaining anti-EGFP, green, and DAPI, blue) in P0 SC section at lumbar level. Scale bar is
100 µm. (E) GDNF positive cells exit cell cycle at 11th embryonic day (E11). Colocalization of BrdU (anti-BrdU, red) and EGFP (anti-EGFP, green) in a P7 descendent
from a pregnant female injected with BrdU at E11. Dapi staining is shown in blue. Scale bars are 100 µm and 40 µm in the inset (white squares). Arrowheads
indicate BrdU/EGFP double positive cells. (F) Expression pattern of GFRα1. SC sections from Gfrα1−(Egfp)/+; Gdnf−(LacZ)/+ mouse at thoracic level (anti-EGFP,
green). CC (blue area drawn over left part) is surrounded by interneurons located in the intermediolateral horn (red square). Motor neurons (MNs) express GFRα1 in
ventral horn (white square). Right panel shows high magnification of squared areas. Scale bar is 200 µm in the left panel and 100 µm in the right panel. (G) Dorsal
corticospinal tract (dCST) is negative for GFRα1 but undergoes recombination in Emx1-Cre line. SC sections from Emx1-Cre/+; Gfrα1Flox/+ (left) and Emx1-Cre/+;
R26R-YFP mice (right) at thoracic level (anti-EGFP, green). The midline is indicated by a white dotted line. Scale bars are 100 µm.
stability. The high correlation between these reports and our
data validates our results in the analysis of GFRα1 expression
pattern, whereas GDNF detection is validated by the analysis
and comparison of two different reporter mice and also by
the high degree of correlation with in situ data (Trupp et al.,
1997; Golden et al., 1999). Another drawback in the use of
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heterozygous KI mice is the presence of only half dose of
the gene, a situation that could alter the normal pattern of
expression. In our case, we have used double heterozygous
mice to map circuits and short-range interactions. However,
the expression pattern of both GFRα1 and GDNF is identical
in heterozygous individuals than in animals carrying both
alleles, strongly arguing against a change in the expression
associated with a half dose of both GDNF and GFRα1. A further
limitation of our study is that, with the present technique,
we can only propose trophic interactions. Studies employing
tracers and genetic ablation in specific cells will be required
to define the role of the GDNF-GFRα1 signaling pathway in
every proposed circuit. Finally, it is noteworthy to remember
that although GDNF signals mainly through GFRα1 (Pascual
et al., 2011), our study does not address GFRα1 independent
signaling.
Adult GFRα1 expression was described in the cerebral
cortex, olfactory areas, hippocampal formation, AMG, OT,
septum, reticular nucleus of the thalamus, MH, mammillary
nucleus, zona incerta, ventral tegmental area, substantia
nigra, IPN, dorsal nucleus of the raphe and the cerebellar
cortex (Trupp et al., 1997). All these brain nuclei are also
reported in our present work, with a greater detail due to
the easier identification of the structures using reporter
mice. For instance, we defined the specific subareas that
contain GFRα1 expressing cells in the cerebral cortex,
hippocampal formation, AMG, and septum. New brain
areas described here as containing GFRα1 expressing neurons
are the CLA, endopiriform nucleus, accumbens, fundus
of striatum, SI, anterior division of the bed nuclei of the
stria terminalis, lateral posterior nucleus of the thalamus,
geniculate complex, anteroperiventricular nucleus, dorsomedial
nucleus, periventricular nucleus, superior colliculus, III, MRN,
periaqueductal gray, anterior pretectal nucleus, nucleus of
the optic tract, pedunculopontine nucleus, principal sensory
nucleus of the trigeminal, parabrachial nucleus, superior
olivary complex, V motor nucleus of trigeminal, superior
nucleus of the raphe and LC. We failed to report expression
in the previously described GFRα1 expressing nuclei: the
glomerular layer of the olfactory areas, red nucleus, Purkinje
and molecular layer of the cerebellum and deep cerebellar
nuclei (Trupp et al., 1997). The differences between both
studies can be due to the different species analyzed, rat
in Trupp et al. (1997) and mouse in the present work.
Interestingly, our data are in almost perfect agreement
with those of the Allen Brain Atlas. Exceptions included
the prefrontal cortex, where in situ hybridization detected
expression that we did not reproduce and the periventricular
nucleus, where we observed GFRα1 expression that was
not confirmed by the data found in the Allen Brain
Atlas.
Regarding adult GDNF expression, a good match was
observed between previous works and our data (Trupp
et al., 1997; Pascual et al., 2008; Hidalgo-Figueroa et al.,
2012). New GDNF expressing areas described here are
the fundus of striatum, SI, nucleus of reunions, rhomboid
nucleus, geniculate complex, parasubthalamic nucleus, superior
colliculus, periaqueductal gray and pedunculopontine nucleus.
In this case, in situ from Allen Brain Atlas did not reproduce
the previously published data (Trupp et al., 1997; Pascual
et al., 2008; Hidalgo-Figueroa et al., 2012) and therefore was
not considered in this work. Similarly, a good agreement
was found between previously described neonatal GDNF and
GFRα1 expression patterns (Golden et al., 1999; Hidalgo-
Figueroa et al., 2012) and our present work, although a greater
detail into the substructures is provided here (Supplementary
Table 4).
Apart from the systematic description of GDNF and GFRα1
expressing areas, our study also reveals that in both perinatal
and mature brains, GFRα1 showed wider expression than
GDNF. Although this was reported (Trupp et al., 1997), it
became more evident in our work due to the visualization of
the GFRα1 axonal fibers (EGFP positive). In particular, the
hippocampal formation, midbrain, and hindbrain are regions
containing a high number of GFRα1 positive neurons but very
localized or even undetectable (hippocampus) expression of
GDNF. The low GDNF brain levels (d’Anglemont de Tassigny
et al., 2015) and the precise localization of GDNF expressing
cells suggest a tight control in their expression. Striatal GDNF
levels are repressed by Sonic hedgehog (Gonzalez-Reyes et al.,
2012) and several adverse effects have been associated with
GDNF treatment (d’Anglemont de Tassigny et al., 2015),
highlighting the importance of a tight control of brain GDNF
levels.
GDNF expression pattern is broader in adult than in perinatal
animals (see below). However, GFRα1 pattern is wider in
perinatal than in adults. Whether this apparent contradiction
is a developmental requirement or a consequence of how
the developmental program refines the expression patterns is
not known. Genetic deficiency of either the ligand or the
receptor did not produce obvious abnormalities, indicating
a role for GDNF signaling in adult more than during
embryogenesis. That is also in agreement with previous reports
describing low GDNF expression in brain during development
(Golden et al., 1999; Hidalgo-Figueroa et al., 2012) and the
minimal neurological phenotype observed in mice lacking
either GDNF (Moore et al., 1996) or GFRα1 (Cacalano
et al., 1998). However, several roles for GDNF have been
described during this period, including an inductive role for
dopaminergic neurons of the substantia nigra compact part
(Peng et al., 2011) and the maintenance of some sensory and
MNs (Moore et al., 1996; Cacalano et al., 1998), suggesting
that more detailed studies will be required to identify subtle
defects.
GDNF was isolated from an immortalized glial cell line (Lin
et al., 1993), however, previous works revealed that GDNF
expression is mainly neuronal in the CNS (Hidalgo-Figueroa
et al., 2012). On the contrary, non-neuronal cells expressed
GFRα1, strongly suggesting that GDNF could exert a trophic
action on this cell population. In a fair agreement, GDNF protects
astrocytes against ischemia (Yu et al., 2007) through ERK/NFκB
signaling pathway (Chu et al., 2008) and the role of non-neuronal
cells in the protection achieved by GDNF in several experimental
models should be now be taken into account.
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Our studies suggested two types of trophic relations,
involving either long- or short-distance interactions between
ligand and receptor expressing cells. Long-distance trophic
support has been described in both the nigrostriatal and
mesolimbic trophic circuits (Pascual et al., 2011), involving
retrograde transport of GDNF (Tomac et al., 1995; Ibáñez,
2007). Expression of GFRα1 in the MH has been previously
notified (Trupp et al., 1997; Glazner et al., 1998; Golden
et al., 1999), although the source of the trophic factor
has not been identified so far. We described here that
GFRα1 positive projecting neurons from the MH send their
axons through the fasciculus retroflexus to innervate the
IPN, whereas no expression was observed in the axons that
innervate the raphe complex, another prominent efferent
pathway of the MH (Herkenham and Nauta, 1979). The
IPN expresses GDNF during perinatal life and could account
for specification or trophic support of habenular neurons
during this developmental period. The fact that GFRα1
expression in this tract is also observed in adult animals
suggests a putative role of trophic signaling in pathology.
In addition to the MH, GFRα1 positive projection neurons
from the SUB send their axons through the fimbria, fornix,
and postcommissural fornix, to reach the mammillary bodies
through the mammillary tract (Raisman et al., 1966; Poletti
and Creswell, 1977). This axonal tract splits to reach anterior
thalamus where we observe GFRα1 positive axons, however,
with the present technique, we cannot determine whether
thalamic terminals belong to subicular neurons and further
analysis using tracers will be required. On the contrary to
the MH/IPN, the mammillary body (MBO) do not express
GDNF.
So far local production of GDNF by interneurons has been
described to signal through GFRα1 positive axonal terminals
of distantly located neurons (Hidalgo-Figueroa et al., 2012).
However, we found brain regions where GDNF could be
anterograde transported to the target neurons, a process that
was previously proposed for several trophic factors (von Bartheld
et al., 2001). A bundle of GDNF positive axons descends
through the internal capsule to innervate the AMG and
the CLA, where we found GFRα1 expressing interneurons.
GDNF expression is scarce in the brain and, therefore, is
tempting to speculate that the axons that profusely innervate
the basolateral AMG and barely the CLA were originated at
the rhomboid nucleus of the thalamus (RH). RH efferent axons
innervate both regions (Vertes et al., 2006, 2015) and also
send projections to the OT, lateral septum, ACB, and caudate-
putamen, all of them containing GFRα1 positive neurons
or axons. As an alternative hypothesis, local GFRα1 axons
are also observed at the level of both the RH and nucleus
of reunions and, therefore, local trophic support could be
anticipated.
Short-distance trophic interactions were observed in several
adult brain regions. Areas with intermingled expression of
GDNF positive neurons and GFRα1 positive cells include ACB,
lateral septum, OT, and SI. It is noteworthy that we did
not observe cellular colocalization of both the ligand and the
receptor, apart from the adult MRN.
Some of the long- and short-distance adult trophic
connections described here participate in the limbic circuits
mediating addiction (Lüthi and Lüscher, 2014), including the
fasciculus retroflexus (Velasquez et al., 2014), the projections
from RH to innervate the basolateral AMG, CLA, tACB, ventral
tegmental area, OT and lateral septum (Lüthi and Lüscher,
2014). Therefore, a conclusion from our work is that GDNF
and GFRα1 are highly expressed in limbic structures, showing
an unexpected complexity in both the number of cells and
the circuits involving trophic factor expression. Our results
suggest that the involvement of GDNF in the regulation of
addiction-related circuits is far more sophisticated than just the
maintenance of the mesolimbic pathway, as previously proposed
(Airavaara et al., 2004; He et al., 2005; Pascual et al., 2008,
2011).
In addition to basal ganglia and limbic systems, GDNF
has been described as important for MNs (Bohn, 2004). In
the neonatal brain, several cranial MNs populations have been
shown to express GFRα1, including III and trigeminal (V)
nucleus (Mikaels et al., 2000). Mice lacking either GFRα1
or GDNF present a similar decrease in the number of
trigeminal MNs (Moore et al., 1996; Cacalano et al., 1998),
however, no effect has been observed in oculomotor neurons
in mice deficient for GDNF (Oppenheim et al., 2000).
Although it is generally believed that GDNF is transported
from the muscle to MNs, approaches using KI animals to
follow GDNF expression in muscle have failed to detect
it (Whitehead et al., 2005). Both motor nuclei contain
GDNF expressing cells (Hidalgo-Figueroa et al., 2012) and
our results indicate a particular situation in the V motor
nucleus, where expression of GDNF and GFRα1 co-exist
in the same neurons. To our knowledge, this is the first
report of a possible autocrine mechanism to maintain a
neuronal population in the CNS. A similar autocrine trophic
mechanism has been proposed for the glomus cells of the
carotid body (Villadiego et al., 2005; Pascual et al., 2008),
a small organ placed at the bifurcation of the carotid
artery responsible for blood oxygen sensing (Weir et al.,
2005).
Another territory where GDNF was proposed as a therapeutic
agent is the SC. Original reports describing the trophic support of
MNs by GDNF (Oppenheim et al., 1995, 2000) were followed by
pre-clinical studies in animal models and clinical trials (Tovar-
Y-Romo et al., 2014). GDNF expression in the perinatal SC
has been described before (Nosrat et al., 1996; Hantman and
Jessell, 2010), but the pattern of expression of GFRα1 has not
been previously addressed. Additionally to MNs, interneurons
surrounding CC are GFRα1 positive and these interneurons have
been proposed as involved in the corticospinal corollary circuit
regulating motor planning and evaluation (Hantman and Jessell,
2010).
GDNF-based therapies designed to improve several neuronal
disorders should take into consideration our findings to improve
the ratio between positive patient’s outcome and adverse effects.
Further work will be required to unveil the logic of trophic
maintenance by the identification of the cell types expressing
both GDNF and GFRα1 in each specific brain area. That will also
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allow for genetic manipulation of both proteins to study their role
in adult CNS function.
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